We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

HospiMedica

Download Mobile App
Recent News Medica 2024 AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

Coronavirus Antibodies Disappear Quickly in People with Mild Illness, But Continue to Offer Protection

By HospiMedica International staff writers
Posted on 23 Jul 2020
A new study has found that coronavirus antibodies decline sharply in the first three months after mild cases of COVID-19, raising concerns over antibody-based “immunity passports,” the possibility of herd immunity and reliability of antibody tests.

In the study conducted by the University of California (Los Angeles, CA, USA), the researchers studied 20 women and 14 men who had recovered from mild cases of COVID-19. Antibody tests were conducted at an average of 36 days and 82 days after the initial symptoms of infection. The researchers found that in people with mild cases of COVID-19, antibodies against SARS-CoV-2 dropped sharply over the first three months after infection, decreasing by roughly half every 36 days. If sustained at that rate, the antibodies would disappear within about a year. Previous reports have suggested that antibodies against the novel coronavirus are short-lived, but the rate at which they decrease has not been carefully defined. This is the first study to carefully estimate the rate at which the antibodies disappear.

Illustration
Illustration

These findings raise concerns about antibody-based “immunity passports,” the potential for herd immunity and the reliability of antibody tests for estimating past infections. In addition, the findings may have implications for the durability of antibody-based vaccines.

Related Links:
University of California


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
New
In-Bed Scale
IBFL500
New
Pneumatic Stool
Avante 5-Leg Pneumatic Stool

Latest COVID-19 News

Low-Cost System Detects SARS-CoV-2 Virus in Hospital Air Using High-Tech Bubbles

World's First Inhalable COVID-19 Vaccine Approved in China

COVID-19 Vaccine Patch Fights SARS-CoV-2 Variants Better than Needles